A detailed history of Great Lakes Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Great Lakes Advisors, LLC holds 862,102 shares of ABBV stock, worth $155 Million. This represents 1.54% of its overall portfolio holdings.

Number of Shares
862,102
Previous 864,210 0.24%
Holding current value
$155 Million
Previous $148 Million 14.85%
% of portfolio
1.54%
Previous 1.39%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$163.84 - $199.33 $345,374 - $420,187
-2,108 Reduced 0.24%
862,102 $170 Million
Q2 2024

Aug 05, 2024

BUY
$154.79 - $180.76 $22.2 Million - $25.9 Million
143,263 Added 19.87%
864,210 $148 Million
Q1 2024

May 08, 2024

BUY
$159.82 - $182.1 $3.79 Million - $4.32 Million
23,744 Added 3.41%
720,947 $131 Million
Q4 2023

Feb 08, 2024

SELL
$137.6 - $154.97 $24.8 Million - $27.9 Million
-179,891 Reduced 20.51%
697,203 $108 Million
Q3 2023

Nov 07, 2023

BUY
$133.59 - $154.65 $24.4 Million - $28.3 Million
182,823 Added 26.33%
877,094 $131 Million
Q2 2023

Aug 10, 2023

SELL
$132.51 - $164.9 $20.7 Million - $25.8 Million
-156,499 Reduced 18.39%
694,271 $93.5 Million
Q1 2023

May 10, 2023

BUY
$144.61 - $166.54 $62.7 Million - $72.2 Million
433,447 Added 103.86%
850,770 $136 Million
Q4 2022

Feb 09, 2023

BUY
$138.31 - $165.87 $1.3 Million - $1.55 Million
9,370 Added 2.3%
417,323 $67.5 Million
Q3 2022

Nov 09, 2022

SELL
$134.21 - $153.93 $3.99 Million - $4.58 Million
-29,728 Reduced 6.79%
407,953 $54.8 Million
Q2 2022

Aug 09, 2022

SELL
$137.62 - $174.96 $17 Million - $21.7 Million
-123,749 Reduced 22.04%
437,681 $67 Million
Q1 2022

May 06, 2022

BUY
$131.98 - $163.75 $13 Million - $16.1 Million
98,413 Added 21.25%
561,430 $91 Million
Q4 2021

Feb 09, 2022

BUY
$107.43 - $135.93 $900,370 - $1.14 Million
8,381 Added 1.84%
463,017 $62.7 Million
Q3 2021

Nov 09, 2021

BUY
$106.4 - $120.78 $203,330 - $230,810
1,911 Added 0.42%
454,636 $49 Million
Q2 2021

Aug 11, 2021

BUY
$105.21 - $117.21 $2.54 Million - $2.83 Million
24,106 Added 5.62%
452,725 $51 Million
Q1 2021

May 03, 2021

SELL
$102.3 - $112.62 $208,794 - $229,857
-2,041 Reduced 0.47%
428,619 $46.4 Million
Q4 2020

Feb 09, 2021

BUY
$80.49 - $108.67 $278,575 - $376,106
3,461 Added 0.81%
430,660 $46.1 Million
Q3 2020

Nov 04, 2020

BUY
$85.91 - $100.83 $66,064 - $77,538
769 Added 0.18%
427,199 $37.4 Million
Q2 2020

Aug 07, 2020

SELL
$73.37 - $98.18 $12.8 Million - $17.1 Million
-174,403 Reduced 29.03%
426,430 $41.9 Million
Q1 2020

May 08, 2020

SELL
$64.5 - $97.79 $3.47 Million - $5.26 Million
-53,741 Reduced 8.21%
600,833 $45.8 Million
Q4 2019

Feb 07, 2020

SELL
$72.13 - $90.25 $3.46 Million - $4.33 Million
-47,988 Reduced 6.83%
654,574 $58 Million
Q3 2019

Nov 06, 2019

SELL
$62.98 - $75.72 $163,055 - $196,039
-2,589 Reduced 0.37%
702,562 $53.2 Million
Q2 2019

Aug 05, 2019

BUY
$65.7 - $83.98 $5.68 Million - $7.26 Million
86,460 Added 13.97%
705,151 $51.3 Million
Q1 2019

May 07, 2019

SELL
$77.14 - $90.79 $720,641 - $848,160
-9,342 Reduced 1.49%
618,691 $49.9 Million
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $1.54 Million - $1.9 Million
-19,751 Reduced 3.05%
628,033 $57.9 Million
Q3 2018

Nov 30, 2018

BUY
$88.91 - $98.84 $56.4 Million - $62.7 Million
634,503 Added 4777.52%
647,784 $61.3 Million
Q3 2018

Nov 15, 2018

SELL
$88.91 - $98.84 $52.3 Million - $58.2 Million
-588,761 Reduced 97.79%
13,281 $1.26 Million
Q2 2018

Aug 13, 2018

SELL
$89.78 - $106.23 $6.78 Million - $8.02 Million
-75,515 Reduced 11.15%
602,042 $55.8 Million
Q1 2018

May 07, 2018

BUY
$92.01 - $123.21 $21.1 Million - $28.3 Million
229,535 Added 51.23%
677,557 $57.5 Million
Q4 2017

Feb 08, 2018

SELL
$89.56 - $98.21 $940,827 - $1.03 Million
-10,505 Reduced 2.29%
448,022 $43.3 Million
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $32 Million - $40.9 Million
458,527
458,527 $40.7 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Great Lakes Advisors, LLC Portfolio

Follow Great Lakes Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Lakes Advisors, LLC with notifications on news.